# Retatrutide: Reference Overview and Reconstitution Notes - facts

Canonical page: https://www.preppinpeppers.com/blogs/the-lab/retatrutide
Type: Lab article

## TL;DR

Retatrutide is a lab-made (synthetic) peptide that switches on three different receptors in the body at once. Those receptors are GIP, GLP-1, and glucagon.

## Facts Index

| Fact ID | Category | Entity | Attribute | Value | Source | Evidence |
|---|---|---|---|---|---|---|
| retatrutide:title | identity | Retatrutide: Reference Overview and Reconstitution Notes | title | Retatrutide: Reference Overview and Reconstitution Notes | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:published | identity | Retatrutide: Reference Overview and Reconstitution Notes | published | 2026-07-10 | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:author | identity | Retatrutide: Reference Overview and Reconstitution Notes | author | Preppin' Peppers Editorial Team | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:topics | identity | Retatrutide: Reference Overview and Reconstitution Notes | topics | Investigational, research | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:summary | content | Retatrutide: Reference Overview and Reconstitution Notes | summary | Retatrutide is a lab-made (synthetic) peptide that switches on three different receptors in the body at once. Those receptors are GIP, GLP-1, and glucagon. | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-1 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-2 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | Retatrutide | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-3 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-4 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | Research context and categorization | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-5 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | Status | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-6 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | Reconstitution notes (general) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-7 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | Dilution and handling notes (compound-specific) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-8 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | Handling and storage | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-9 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | Related reading | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-10 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | Tools and supplies | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:section-12 | content | Retatrutide: Reference Overview and Reconstitution Notes | section | What the research community gets wrong about retatrutide | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/blogs/the-lab/retatrutide |
| retatrutide:product-gansulin-metal-peptide-pen | products | Retatrutide: Reference Overview and Reconstitution Notes | references product | Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/products/gansulin-metal-peptide-pen |
| retatrutide:product-gansulin-3ml-cartridge | products | Retatrutide: Reference Overview and Reconstitution Notes | references product | Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.preppinpeppers.com/products/gansulin-3ml-cartridge |
| retatrutide:source-pubmed-ncbi-nlm-nih-gov | source | Retatrutide: Reference Overview and Reconstitution Notes | cites | Jastreboff et al., N Engl J Med 2023: Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://pubmed.ncbi.nlm.nih.gov/37366315/ |
| retatrutide:source-pmc-ncbi-nlm-nih-gov | source | Retatrutide: Reference Overview and Reconstitution Notes | cites | Katsi et al., Biomolecules 2025: Retatrutide-A Game Changer in Obesity Pharmacotherapy - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://pmc.ncbi.nlm.nih.gov/articles/PMC12190491/ |
| retatrutide:source-pmc-ncbi-nlm-nih-gov-2 | source | Retatrutide: Reference Overview and Reconstitution Notes | cites | Pallavi et al., Maedica (Bucur) 2025: Efficacy and Safety of Retatrutide in the Treatment of Diabetes and/or Obesity Comorbid with Chronic Kidney disease: a Systematic Review and Meta-Analysis - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://pmc.ncbi.nlm.nih.gov/articles/PMC12767911/ |
| retatrutide:source-www-uniprot-org | source | Retatrutide: Reference Overview and Reconstitution Notes | cites | UniProtKB P43220: Glucagon-like peptide 1 receptor (GLP1R, Homo sapiens), UniProt release 2026-03 - www.uniprot.org | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://www.uniprot.org/uniprotkb/P43220/entry |
| retatrutide:source-clinicaltrials-gov | source | Retatrutide: Reference Overview and Reconstitution Notes | cites | ClinicalTrials.gov NCT06808802 (Phase 1, completed, first posted 2025-02-05): To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants - clinicaltrials.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://clinicaltrials.gov/study/NCT06808802 |
| retatrutide:source-pmc-ncbi-nlm-nih-gov-3 | source | Retatrutide: Reference Overview and Reconstitution Notes | cites | Giblin et al., Diabetes Obes Metab 2026: Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/retatrutide) | https://pmc.ncbi.nlm.nih.gov/articles/PMC12673447/ |

## FAQ

### What receptors does retatrutide target?

Retatrutide is a triple agonist that simultaneously activates the GIP, GLP-1, and glucagon receptors, distinguishing it from dual GIP/GLP-1 agonists in the same metabolic research category.

### What is the regulatory status of retatrutide?

No. As of mid-2026, retatrutide remains investigational and is in Phase 3 clinical trials. It is not approved by any regulator, including the FDA, and is not a licensed product for any indication.

### How do you reconstitute a lyophilized retatrutide vial for lab use?

Add bacteriostatic water to the lyophilized powder; concentration (mg/mL) equals peptide mass (mg) divided by solvent volume (mL) added. A peptide calculator can confirm the figures before use.

---
Built from PreppinPeppers store data and verified sources only. Same content for every visitor. Research and educational use only, not for human or veterinary use.